Jenburkt Pharmaceuticals share price
You have to be logged in to add this to Watchlist.Jenburkt Pharmaceuticals is trading 6.24% upper at Rs 1,234.90 as compared to its last closing price. Jenburkt Pharmaceuticals has been trading in the price range of 1,260.00 & 1,162.45. Jenburkt Pharmaceuticals has given 70.90% in this year & 3.46% in the last 5 days.
Jenburkt Pharmaceuticals has TTM P/E ratio 15.45 as compared to the sector P/E of 33.29.
The company posted a net profit of 9.60 Crores in its last quarter.
Listed peers of Jenburkt Pharmaceuticals include Lyka Labs (2.55%), Zim Laboratories (2.74%), Jenburkt Pharmaceuticals (6.24%) etc.
Jenburkt Pharmaceuticals has a 53.29% public holding. The FII holding in Jenburkt Pharmaceuticals was at 1.38% in 30 Sep 2023. The FII holding has decreased from the last quarter.
Jenburkt Pharmaceuticals share price range
|
| ||||
|
| ||||
Jenburkt Pharmaceuticals share Key Metrics
| Market Cap ( ₹ Cr.) | 512.98 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Jenburkt Pharmaceuticals Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 05-Nov-24 | Quarterly Results |
| 26-Jul-24 | Quarterly Results |
| 28-May-24 | Audited Results & Dividend |
| 06-Feb-24 | Quarterly Results |
| 07-Nov-23 | Quarterly Results |
| 08-Aug-23 | Quarterly Results |
| 23-May-23 | Audited Results, Dividend & A.G.M. |
| 07-Feb-23 | Quarterly Results |
| 01-Dec-22 | Buy Back of Shares |
| 08-Nov-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 26-Jul-23 | 24-May-23 | AGM |
| 29-Jul-22 | 27-May-22 | AGM |
| 07-Sep-21 | 02-Jun-21 | AGM |
| - | 30-May-24 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 28-May-24 | - | 23-Jul-24 | 15.3 |
| 23-May-23 | - | 19-Jul-23 | 14.4 |
| 27-May-22 | - | 21-Jul-22 | 12 |
| 02-Jun-21 | - | 30-Aug-21 | 10.2 |
FAQs about Jenburkt Pharmaceuticals share price
Jenburkt Pharmaceuticals is trading at 1234.90 as on Mon Nov 25 2024 09:59:56. This is 6.24% upper as compared to its previous closing price of 1162.35.
The market capitalization of Jenburkt Pharmaceuticals is 512.98 Cr as on Mon Nov 25 2024 09:59:56.
The 52 wk high for Jenburkt Pharmaceuticals is 1375.00 whereas the 52 wk low is 643.20
Jenburkt Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 15.45
- Sector P/E: 33.29
- Dividend Yield: 1.32%
- D/E ratio: 0.01
Jenburkt Pharmaceuticals reported a net profit of 25.98 Cr in 2024.
Jenburkt Pharmaceuticals Quick Links
Jenburkt Pharmaceuticals Dividend Jenburkt Pharmaceuticals Bonus Jenburkt Pharmaceuticals News Jenburkt Pharmaceuticals AGM Jenburkt Pharmaceuticals Rights Jenburkt Pharmaceuticals Splits Jenburkt Pharmaceuticals Board Meetings Jenburkt Pharmaceuticals Key Metrics Jenburkt Pharmaceuticals Shareholdings Jenburkt Pharmaceuticals Profit Loss Jenburkt Pharmaceuticals Balance Sheet Jenburkt Pharmaceuticals Cashflow Jenburkt Pharmaceuticals Q1 Results Jenburkt Pharmaceuticals Q2 Results Jenburkt Pharmaceuticals Q3 Results Jenburkt Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks